ALIUXTA Trademark

Trademark Overview


On Wednesday, August 30, 2017, a trademark application was filed for ALIUXTA with the United States Patent and Trademark Office. The USPTO has given the ALIUXTA trademark a serial number of 87590070. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 4, 2025. This trademark is owned by Glaxo Group Limited. The ALIUXTA trademark is filed in the Pharmaceutical Products category with the following description:

(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
aliuxta

General Information


Serial Number87590070
Word MarkALIUXTA
Filing DateWednesday, August 30, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 4, 2025
Registration Number5568530
Registration DateTuesday, September 25, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 10, 2018

Trademark Statements


Goods and Services(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "ALIUXTA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 4, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Saturday, September 2, 2017NEW APPLICATION ENTERED
Thursday, May 31, 2018ASSIGNED TO LIE
Wednesday, June 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 14, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, November 14, 2017TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, November 30, 2017ASSIGNED TO EXAMINER
Thursday, November 30, 2017NON-FINAL ACTION WRITTEN
Thursday, November 30, 2017NON-FINAL ACTION E-MAILED
Thursday, November 30, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 24, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 7, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 20, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 10, 2018PUBLISHED FOR OPPOSITION
Tuesday, July 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 25, 2018REGISTERED-PRINCIPAL REGISTER
Monday, August 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 1, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, September 25, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 4, 2025CANCELLED SEC. 8 (6-YR)